SANUWAVE Health Significantly Narrows Q1 Loss to $1.44M, EPS Improves to $(0.17)
summarizeSummary
SANUWAVE Health reported its first-quarter 2026 results, showing a significant reduction in net loss to $1.44 million, a substantial improvement from a $6.12 million loss in the prior year's quarter. Diluted loss per share also improved to $(0.17) from $(0.72). Revenue saw a modest 3.1% year-over-year increase to $9.62 million, driven by higher disposable volumes despite declining system average selling prices. This earnings report provides a fresh financial update following recent corporate governance concerns and a restatement in the prior annual 10-K. The substantial improvement in profitability metrics, even while still reporting a loss, is a material positive development for the company, especially as its stock trades near its 52-week low. Traders will watch for continued progress in loss reduction and sustainable revenue growth.
At the time of this announcement, SNWV was trading at $16.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $137.9M. The 52-week trading range was $15.36 to $46.59. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.